Thyzol 20 Tablet

About Thyzol 20 Tablet

Thyzol 20 is a tablet made by Nuvista Pharma Ltd that contains the generic medicine methimazole, an anti-thyroid drug. It is used in people whose thyroid gland makes too much thyroid hormone.

There are 5 brands of Methimazole listed in Bangladesh.

What is Thyzol 20 Tablet?

Thyzol 20 is a 20 mg tablet of methimazole, an anti-thyroid drug from Nuvista Pharma Ltd. It works by reducing the amount of thyroid hormone the thyroid gland makes. It is used in Graves' disease with hyperthyroidism, or in toxic multinodular goiter, when surgery or radioactive iodine is not a suitable option. It is also used to ease hyperthyroid symptoms while a person prepares for thyroid surgery or radioactive iodine treatment. Methimazole does not undo thyroid hormone already stored in the gland or already in the blood. The doctor decides the dose and how long it is taken.

Uses of Thyzol 20

Thyzol 20 is used to treat an overactive thyroid gland. It is given to people with Graves' disease or toxic multinodular goiter when surgery or radioactive iodine therapy is not an appropriate option. It is also used to relieve hyperthyroid symptoms while someone prepares for thyroid surgery or radioactive iodine therapy. It lowers the amount of new thyroid hormone the gland makes, but it does not remove hormone already stored or already in the blood.

How to use Thyzol 20

Thyzol 20 is taken by mouth. The doctor decides the dose, how often it is taken and how long the course lasts, so follow the instructions given to you. The daily amount is usually split into doses taken at regular intervals through the day. Do not change the dose or stop early on your own. If you miss a dose, ask your doctor or pharmacist what to do. Keep the tablet in a cool, dry place away from light and children.

Side effects of Thyzol 20

Some people may get a skin rash, itching or hives, nausea, vomiting, stomach discomfort, joint or muscle pain, headache, tingling, loss of taste, hair loss, drowsiness, dizziness, swelling, yellowing of the skin or eyes, or enlarged lymph glands. Rare but serious effects include low white blood cell counts, low platelets, anaemia, liver inflammation and kidney inflammation. Contact your doctor if you feel unwell or notice unusual symptoms; the doctor will advise what to do.

Safety and precautions

Do not take Thyzol 20 if you are allergic to methimazole or to any other ingredient in the tablet. Tell your doctor before starting if you are pregnant, planning a pregnancy or breastfeeding, because methimazole can cross the placenta and has been linked to birth defects, especially in the first trimester, and it passes into breast milk. Your doctor may choose another medicine in these situations. Tell your doctor about all other medicines you take, including blood thinners, beta-blockers and digitalis, and about any liver or blood problems. Ask your doctor first if any of these apply to you.

Frequently asked questions

What is Thyzol 20 used for and what kind of medicine is it?

It is an anti-thyroid tablet containing methimazole. It is used in Graves' disease or toxic multinodular goiter when surgery or radioactive iodine is not suitable, and to ease symptoms before thyroid surgery or radioactive iodine treatment. It lowers the amount of new thyroid hormone the gland makes.

How should Thyzol 20 be taken?

It is swallowed by mouth, and the doctor decides the dose, how often it is taken and how long the course lasts. The daily amount is usually divided into doses taken at regular intervals. Follow your doctor's instructions and do not change the dose or stop on your own.

Who should avoid Thyzol 20 or ask the doctor first?

Do not use it if you are allergic to methimazole or any ingredient of the tablet. Ask your doctor first if you are pregnant, planning a pregnancy or breastfeeding, have liver or blood problems, or take other medicines such as blood thinners, beta-blockers or digitalis.

Can Thyzol 20 be used during pregnancy or breastfeeding?

Methimazole can cross the placenta and has been linked to birth defects, especially in the first trimester, and it passes into breast milk. Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding, because another medicine may be chosen. Do not start or stop it without your doctor's advice.

Indications

Methimazole is indicated:
  • In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.
  • To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.

Pharmacology

Methimazole inhibits the synthesis of thyroid hormones and thus is effective in the treatment of hyperthyroidism. The drug does not inactivate existing thyroxine and triiodothyronine that are stored in the thyroid or circulating in the blood nor does it interfere with the effectiveness of thyroid hormones given by mouth or by injection. Methimazole is readily absorbed in the gastrointestinal tract, metabolized in the liver, and excreted in the urine.

Dosage & Administration

Methimazole is administered orally. The total daily dosage is usually given in 3 divided doses at approximately 8 hour intervals.

Adults: The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8 hour intervals. The maintenance dosage is 5 to 15 mg daily.

Pediatric: Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8 hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.

Use in children & adolescents: Because of post-marketing reports of severe liver injury in pediatric patient treated with propylthiouracil, Methimazole is the preferred choice when an antithyroid drug is required for a pediatric patient.

Interaction

With medicine: Anticoagulants (oral)- Due to potential inhibition of vitamin K activity by methimazole, the activity of oral anticoagulants (e.g., warfarin) may be increased; additional monitoring of PT/INR should be considered, especially before surgical procedures. β-adrenergic blocking agents- Hyperthyroidism may cause an increased clearance of beta-blockers with a high extraction ratio. A dose reduction of beta-adrenergic blockers may be needed when a hyperthyroid patient becomes euthyroid. Digitalis glycosides- Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; a reduced dosage of digitalis glycosides may be needed. Theophylline- Theophylline clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; a reduced dose of theophylline may be needed.

With food: Always take at the same moment in regard to meals, food may affect absorption unpredictably.

Contraindications

Methimazole is contraindicated in the presence of hypersensitivity to the drug or any of the other product components.

Side Effects

Common: Skin rash, urticaria, nausea, vomiting, epigastric distress, arthralgia, paresthesia, loss of taste, abnormal loss of hair, myalgia, headache, pruritus, drowsiness, neuritis, edema, vertigo, skin pigmentation, jaundice, sialadenopathy, and lymphadenopathy.

Rare: Agranulocytosis, granulocytopenia, thrombocytopenia and aplastic anemia, drug fever, a lupus-like syndrome, insulin autoimmune syndrome (which can result in hypoglycemic coma), hepatitis (jaundice may persist for several weeks after discontinuation of the drug), periarteritis, and hypoprothrombinemia. Nephritis occurs very rarely.

Pregnancy & Lactation

Pregnancy Category D. Due to the rare occurrence of congenital malformations associated with methimazole use, it may be appropriate to use other agents in pregnant women requiring treatment for hyperthyroidism particularly in the first trimester of pregnancy. Methimazole is excreted into breast milk. However, several studies found no effect on clinical status in nursing infants of mothers taking methimazole, particularly if thyroid function is monitored at frequent (weekly or biweekly) intervals.

Precautions & Warnings

Congenital Malformations: Methimazole readily crosses the placental membranes and can cause fetal harm, particularly when administered in the first trimester of pregnancy. If Methimazole is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be warned of the potential hazard to the fetus. Since some congenital defects have been reported in offspring of patients treated with Methimazole, it may be appropriate to use other agents in pregnant women requiring treatment for hyperthyroidism, particularly in the first trimester of pregnancy. If Methimazole is used, the lowest possible dose to control the disease should be given.

Agranulocytosis: Agranulocytosis is potentially a life-threatening adverse reaction of Methimazole therapy. Patients should be instructed to immediately report to their physicians if any symptoms suggestive of agranulocytosis, such as fever or sore throat occur. Leukopenia, thrombocytopenia, and aplastic anemia (pancytopenia) may also occur. The drug should be discontinued in the presence of agranulocytosis, aplastic anemia (pancytopenia), ANCA-positive vasculitis, hepatitis, or exfoliative dermatitis and the patient’s bone marrow indices should be monitored.

Liver Toxicity: Although there have been reports of hepatotoxicity associated with Methimazole, the risk of hepatotoxicity appears to be less with methimazole than with propylthiouracil, especially in the pediatric population. Drug treatment should be discontinued promptly in the event of clinically significant evidence of liver abnormality including hepatic transaminase values exceeding 3 times the upper limit of normal.

Hypothyroidism: Methimazole can cause hypothyroidism necessitating routine monitoring of TSH and free T4 levels with adjustments in dosing to maintain a euthyroid state. Because the drug readily crosses placental membranes, Methimazole can cause fetal goiter and cretinism when administered to a pregnant woman. For this reason, it is important that a sufficient, but not excessive, dose be given during pregnancy. Because Methimazole may cause hypoprothrombinemia and bleeding, prothrombin time should be monitored during therapy with the drug, especially before surgical procedures. Thyroid function tests should be monitored periodically during therapy. Once clinical evidence of hyperthyroidism has resolved, the finding of a rising serum TSH indicates that a lower maintenance dose of Methimazole should be employed.

Overdose Effects

Symptoms may include nausea, vomiting, epigastric distress, headache, fever, joint pain, pruritus, and edema. Aplastic anemia or agranulocytosis may be manifested in hours to days. Less frequent events are hepatitis, nephrotic syndrome, exfoliative dermatitis, neuropathies, and CNS stimulation or depression. In the event of an overdose, appropriate supportive treatment should be initiated as dictated by the patient’s medical status.

Storage Conditions

Store in a cool (below 30°C) and dry place, away from light and children.

Alternative brands of Methimazole

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.